title: Invasive cutaneous mucormycosis caused by Absidia corymbifera after allogeneic bone marrow transplantation.
abstract: Mucormycotic infections caused by fungi of the families Rhizopus, Mucor or Absidia are rare and usually associated with diabetes or immunosuppression. We describe a patient with invasive necrotizing cutaneous mucormycosis caused by Absidia corymbifera shortly after allogeneic BMT. The infection was successfully treated with surgical debridement and liposomal amphotericin B for 6 weeks. Recognition of these rare infections requires a high index of suspicion. These patients should be evaluated with tissue biopsy and cultures and treated without delay.
authors.affiliation: Department of Medicine, Kuopio University Hospital, Finland.
authors.forename: E
authors.initials: E
authors.lastname: Jantunen
authors.forename: E
authors.initials: E
authors.lastname: Kolho
authors.forename: P
authors.initials: P
authors.lastname: Ruutu
authors.forename: P
authors.initials: P
authors.lastname: Koukila-Kähkölä
authors.forename: M
authors.initials: M
authors.lastname: Virolainen
authors.forename: E
authors.initials: E
authors.lastname: Juvonen
authors.forename: L
authors.initials: L
authors.lastname: Volin
mesh_terms: D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000753:Anemia, Refractory / Q000628:therapy*; D000935:Antifungal Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003646:Debridement; D003881:Dermatomycoses / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology / Q000473:pathology / Q000601:surgery; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D009090:Mucorales / Q000302:isolation & purification*; D009091:Mucormycosis / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology / Q000473:pathology / Q000601:surgery
chemical_list: D000935:Antifungal Agents; D000666:Amphotericin B